BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

455 related articles for article (PubMed ID: 27186904)

  • 1. Using reverse docking for target identification and its applications for drug discovery.
    Lee A; Lee K; Kim D
    Expert Opin Drug Discov; 2016 Jul; 11(7):707-15. PubMed ID: 27186904
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Molecular Docking: Shifting Paradigms in Drug Discovery.
    Pinzi L; Rastelli G
    Int J Mol Sci; 2019 Sep; 20(18):. PubMed ID: 31487867
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Reverse docking: a powerful tool for drug repositioning and drug rescue.
    Kharkar PS; Warrier S; Gaud RS
    Future Med Chem; 2014 Mar; 6(3):333-42. PubMed ID: 24575968
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Automated docking for novel drug discovery.
    Bello M; Martínez-Archundia M; Correa-Basurto J
    Expert Opin Drug Discov; 2013 Jul; 8(7):821-34. PubMed ID: 23642085
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Understanding the challenges of protein flexibility in drug design.
    Antunes DA; Devaurs D; Kavraki LE
    Expert Opin Drug Discov; 2015 Dec; 10(12):1301-13. PubMed ID: 26414598
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Computational polypharmacology: a new paradigm for drug discovery.
    Chaudhari R; Tan Z; Huang B; Zhang S
    Expert Opin Drug Discov; 2017 Mar; 12(3):279-291. PubMed ID: 28067061
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Improving the efficacy-safety balance of polypharmacology in multi-target drug discovery.
    Ravikumar B; Aittokallio T
    Expert Opin Drug Discov; 2018 Feb; 13(2):179-192. PubMed ID: 29233023
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Applications of the NRGsuite and the Molecular Docking Software FlexAID in Computational Drug Discovery and Design.
    Morency LP; Gaudreault F; Najmanovich R
    Methods Mol Biol; 2018; 1762():367-388. PubMed ID: 29594781
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Use of machine learning approaches for novel drug discovery.
    Lima AN; Philot EA; Trossini GH; Scott LP; Maltarollo VG; Honorio KM
    Expert Opin Drug Discov; 2016; 11(3):225-39. PubMed ID: 26814169
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Using quantitative systems pharmacology for novel drug discovery.
    Pérez-Nueno VI
    Expert Opin Drug Discov; 2015 Dec; 10(12):1315-31. PubMed ID: 26328768
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Application of Reverse Docking in the Research of Small Molecule Drugs and Traditional Chinese Medicine.
    Wang H; He H; Zhang T; Jiang J
    Biol Pharm Bull; 2022 Jan; 45(1):19-26. PubMed ID: 34719576
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Reverse Docking for the Identification of Molecular Targets of Anticancer Compounds.
    Ruiz-Moreno AJ; Dömling A; Velasco-Velázquez MA
    Methods Mol Biol; 2021; 2174():31-43. PubMed ID: 32813243
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The importance of employing computational resources for the automation of drug discovery.
    Rosales-Hernández MC; Correa-Basurto J
    Expert Opin Drug Discov; 2015 Mar; 10(3):213-9. PubMed ID: 25682781
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Docking and Virtual Screening in Drug Discovery.
    Kontoyianni M
    Methods Mol Biol; 2017; 1647():255-266. PubMed ID: 28809009
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Predicting targeted polypharmacology for drug repositioning and multi- target drug discovery.
    Liu X; Zhu F; Ma XH; Shi Z; Yang SY; Wei YQ; Chen YZ
    Curr Med Chem; 2013; 20(13):1646-61. PubMed ID: 23410165
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The role of experimental and computational structural approaches in 7TM drug discovery.
    Topiol S; Sabio M
    Expert Opin Drug Discov; 2015 Oct; 10(10):1071-84. PubMed ID: 26211671
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Protein-Ligand Docking in Drug Design: Performance Assessment and Binding-Pose Selection.
    Ballante F
    Methods Mol Biol; 2018; 1824():67-88. PubMed ID: 30039402
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Overview on the current status of virtual high-throughput screening and combinatorial chemistry approaches in multi-target anticancer drug discovery; Part I.
    Geromichalos GD; Alifieris CE; Geromichalou EG; Trafalis DT
    J BUON; 2016; 21(4):764-779. PubMed ID: 27685895
    [TBL] [Abstract][Full Text] [Related]  

  • 19. An update on Drug Repurposing: Re-written saga of the drug's fate.
    Gns HS; Gr S; Murahari M; Krishnamurthy M
    Biomed Pharmacother; 2019 Feb; 110():700-716. PubMed ID: 30553197
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Herbalog: A tool for target-based identification of herbal drug efficacy through molecular docking.
    Wang Y; Hu JS; Lin HQ; Ip TM; Wan DC
    Phytomedicine; 2016 Nov; 23(12):1469-1474. PubMed ID: 27765367
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 23.